Figure 1: Estimating and Treating Atherosclerotic Cardiovascular Disease (ASCVD) Risk in People with HIV. *In patients on atazanavir/cobicistat, atorvastatin is contraindicated. In patients on darunavir/ritonavir, darunavir/cobicistat, or elvitegravir/cobicistat, the maximum recommended dose of atorvastatin is 20 mg daily. Similarly, atazanavir/ritonavir and lopinavir/cobicistat, the maximum recommended dose of rosuvastatin is 10 mg daily.